FDA
approval
· 2016-04-13
FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)
Summary
The FDA approved a supplemental application for LANTUS SOLOSTAR (insulin glargine) submitted by Sanofi‑Aventis U.S. LLC, authorizing changes under a supplementa…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LANTUS SOLOSTAR (INSULIN GLARGINE)